Mettler-Toledo International Inc.
Mettler-Toledo International Inc. 0K10.L Peers
See (0K10.L) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Pharmaceuticals Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0K10.L | £1,171.16 | -1.99% | 24.3B | 34.40 | £34.05 | N/A |
| 0R0H.L | £406.26 | -2.11% | 153.4B | 21.17 | £19.19 | +0.50% |
| 0QZU.L | £457.48 | -0.31% | 117.5B | 48.28 | £9.48 | N/A |
| 0M3Q.L | £164.76 | -1.78% | 73.4B | 37.80 | £4.36 | +1.14% |
| 0R2M.L | £526.06 | +1.00% | 55.8B | 7.48 | £70.31 | +0.33% |
| 0HD2.L | £306.29 | +2.70% | 39.9B | -40.89 | -£7.49 | N/A |
| 0RD1.L | £603.79 | -1.30% | 36.9B | -475.43 | -£1.27 | N/A |
| 0HAV.L | £118.01 | -1.21% | 33.5B | 28.47 | £4.15 | +0.82% |
| 0JDM.L | £158.43 | -0.63% | 27.4B | 28.61 | £5.54 | N/A |
| 0REZ.L | £195.80 | +0.67% | 24B | 33.37 | £5.87 | +0.38% |
Stock Comparison
0K10.L vs 0R0H.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0R0H.L has a market cap of 153.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0R0H.L trades at £406.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0R0H.L's P/E ratio is 21.17. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R0H.L's ROE of +0.13%. Regarding short-term risk, 0K10.L is less volatile compared to 0R0H.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QZU.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QZU.L has a market cap of 117.5B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QZU.L trades at £457.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QZU.L's P/E ratio is 48.28. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QZU.L's ROE of -0.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0QZU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0M3Q.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0M3Q.L has a market cap of 73.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0M3Q.L trades at £164.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0M3Q.L's P/E ratio is 37.80. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0M3Q.L's ROE of +0.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0M3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R2M.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0R2M.L has a market cap of 55.8B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0R2M.L trades at £526.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0R2M.L's P/E ratio is 7.48. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R2M.L's ROE of +0.15%. Regarding short-term risk, 0K10.L is less volatile compared to 0R2M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HD2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HD2.L has a market cap of 39.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HD2.L trades at £306.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HD2.L's P/E ratio is -40.89. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HD2.L's ROE of +9.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0HD2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RD1.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RD1.L has a market cap of 36.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RD1.L trades at £603.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RD1.L's P/E ratio is -475.43. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RD1.L's ROE of +0.14%. Regarding short-term risk, 0K10.L is less volatile compared to 0RD1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HAV.L has a market cap of 33.5B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HAV.L trades at £118.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HAV.L's P/E ratio is 28.47. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HAV.L's ROE of +0.21%. Regarding short-term risk, 0K10.L is less volatile compared to 0HAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDM.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JDM.L has a market cap of 27.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JDM.L trades at £158.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JDM.L's P/E ratio is 28.61. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDM.L's ROE of +0.21%. Regarding short-term risk, 0K10.L is less volatile compared to 0JDM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0REZ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0REZ.L has a market cap of 24B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0REZ.L trades at £195.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0REZ.L's P/E ratio is 33.37. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0REZ.L's ROE of +0.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0REZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LTI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0LTI.L has a market cap of 20.5B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0LTI.L trades at £344.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0LTI.L's P/E ratio is 30.15. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LTI.L's ROE of +0.39%. Regarding short-term risk, 0K10.L is less volatile compared to 0LTI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R1B.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0R1B.L has a market cap of 19.2B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0R1B.L trades at £131.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0R1B.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R1B.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0R1B.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0SAN.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0SAN.L has a market cap of 18.5B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0SAN.L trades at £42.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0SAN.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0SAN.L's ROE of +0.00%. Regarding short-term risk, 0K10.L is less volatile compared to 0SAN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RQO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RQO.L has a market cap of 16.8B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RQO.L trades at £254.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RQO.L's P/E ratio is -200.10. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RQO.L's ROE of +0.18%. Regarding short-term risk, 0K10.L is less volatile compared to 0RQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JAV.L has a market cap of 16.7B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JAV.L trades at £98.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JAV.L's P/E ratio is -26.11. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JAV.L's ROE of -4.47%. Regarding short-term risk, 0K10.L is less volatile compared to 0JAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J8Z.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0J8Z.L has a market cap of 13.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0J8Z.L trades at £87.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0J8Z.L's P/E ratio is 19.21. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J8Z.L's ROE of -0.46%. Regarding short-term risk, 0K10.L is less volatile compared to 0J8Z.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J9P.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0J9P.L has a market cap of 13.3B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0J9P.L trades at £68.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0J9P.L's P/E ratio is 16.34. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J9P.L's ROE of +0.01%. Regarding short-term risk, 0K10.L is less volatile compared to 0J9P.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K6R.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0K6R.L has a market cap of 12.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0K6R.L trades at £124.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0K6R.L's P/E ratio is 171.11. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K6R.L's ROE of +0.12%. Regarding short-term risk, 0K10.L is less volatile compared to 0K6R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IJO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IJO.L has a market cap of 11.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IJO.L trades at £41.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IJO.L's P/E ratio is 45.06. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IJO.L's ROE of +0.29%. Regarding short-term risk, 0K10.L is less volatile compared to 0IJO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HNC.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HNC.L has a market cap of 10.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HNC.L trades at £56.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HNC.L's P/E ratio is 264.56. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HNC.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0HNC.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LSZ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0LSZ.L has a market cap of 9.8B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0LSZ.L trades at £11.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0LSZ.L's P/E ratio is 1.57. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LSZ.L's ROE of -0.55%. Regarding short-term risk, 0K10.L is less volatile compared to 0LSZ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HOJ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HOJ.L has a market cap of 8.3B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HOJ.L trades at £128.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HOJ.L's P/E ratio is -11.59. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HOJ.L's ROE of -0.49%. Regarding short-term risk, 0K10.L is more volatile compared to 0HOJ.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0I3Q.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0I3Q.L has a market cap of 7.5B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0I3Q.L trades at £70.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0I3Q.L's P/E ratio is 77.53. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0I3Q.L's ROE of +0.20%. Regarding short-term risk, 0K10.L is less volatile compared to 0I3Q.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J2O.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0J2O.L has a market cap of 6.7B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0J2O.L trades at £54.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0J2O.L's P/E ratio is 18.03. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J2O.L's ROE of +1.22%. Regarding short-term risk, 0K10.L is less volatile compared to 0J2O.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JDI.L has a market cap of 5.6B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JDI.L trades at £35.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JDI.L's P/E ratio is -1258.21. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDI.L's ROE of -0.92%. Regarding short-term risk, 0K10.L is more volatile compared to 0JDI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0VGI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0VGI.L has a market cap of 5.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0VGI.L trades at £31.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0VGI.L's P/E ratio is -13.01. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0VGI.L's ROE of +0.19%. Regarding short-term risk, 0K10.L is less volatile compared to 0VGI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HKF.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HKF.L has a market cap of 5.2B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HKF.L trades at £105.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HKF.L's P/E ratio is -28.30. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HKF.L's ROE of -3.64%. Regarding short-term risk, 0K10.L is less volatile compared to 0HKF.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QQO.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QQO.L has a market cap of 4.3B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QQO.L trades at £94.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QQO.L's P/E ratio is 4.29. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QQO.L's ROE of +0.17%. Regarding short-term risk, 0K10.L is less volatile compared to 0QQO.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QND.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QND.L has a market cap of 4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QND.L trades at £53.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QND.L's P/E ratio is 33.22. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QND.L's ROE of +0.09%. Regarding short-term risk, 0K10.L is less volatile compared to 0QND.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0L35.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0L35.L has a market cap of 3.7B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0L35.L trades at £36.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0L35.L's P/E ratio is -8.48. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0L35.L's ROE of -0.20%. Regarding short-term risk, 0K10.L is less volatile compared to 0L35.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0Y5E.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0Y5E.L has a market cap of 3.7B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0Y5E.L trades at £27.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0Y5E.L's P/E ratio is -33.04. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0Y5E.L's ROE of -0.04%. Regarding short-term risk, 0K10.L is less volatile compared to 0Y5E.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0ILL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0ILL.L has a market cap of 2.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0ILL.L trades at £56.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0ILL.L's P/E ratio is 16.87. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0ILL.L's ROE of +0.26%. Regarding short-term risk, 0K10.L is less volatile compared to 0ILL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0VQA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0VQA.L has a market cap of 2.8B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0VQA.L trades at £26.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0VQA.L's P/E ratio is -35.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0VQA.L's ROE of -0.14%. Regarding short-term risk, 0K10.L is less volatile compared to 0VQA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0GZB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0GZB.L has a market cap of 2.3B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0GZB.L trades at £203.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0GZB.L's P/E ratio is 31.04. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0GZB.L's ROE of +0.01%. Regarding short-term risk, 0K10.L is more volatile compared to 0GZB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0I5P.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0I5P.L has a market cap of 2.2B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0I5P.L trades at £32.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0I5P.L's P/E ratio is -24.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0I5P.L's ROE of -0.64%. Regarding short-term risk, 0K10.L is more volatile compared to 0I5P.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QLN.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QLN.L has a market cap of 2.1B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QLN.L trades at £165.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QLN.L's P/E ratio is 16.79. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QLN.L's ROE of +0.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0QLN.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HB0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HB0.L has a market cap of 2B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HB0.L trades at £34.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HB0.L's P/E ratio is -5.35. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HB0.L's ROE of +0.59%. Regarding short-term risk, 0K10.L is more volatile compared to 0HB0.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HF9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HF9.L has a market cap of 1.9B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HF9.L trades at £6.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HF9.L's P/E ratio is -6.33. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HF9.L's ROE of -0.17%. Regarding short-term risk, 0K10.L is less volatile compared to 0HF9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LB2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0LB2.L has a market cap of 1.8B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0LB2.L trades at £32.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0LB2.L's P/E ratio is 24.73. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LB2.L's ROE of +0.06%. Regarding short-term risk, 0K10.L is more volatile compared to 0LB2.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IMT.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IMT.L has a market cap of 1.4B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IMT.L trades at £51.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IMT.L's P/E ratio is -20.47. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IMT.L's ROE of +0.00%. Regarding short-term risk, 0K10.L is more volatile compared to 0IMT.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IDA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IDA.L has a market cap of 1.2B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IDA.L trades at £10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IDA.L's P/E ratio is 13.79. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IDA.L's ROE of -0.10%. Regarding short-term risk, 0K10.L is less volatile compared to 0IDA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KCS.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0KCS.L has a market cap of 1.1B. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0KCS.L trades at £1.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0KCS.L's P/E ratio is -7.49. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KCS.L's ROE of -0.03%. Regarding short-term risk, 0K10.L is less volatile compared to 0KCS.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RGI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RGI.L has a market cap of 999.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RGI.L trades at £58.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RGI.L's P/E ratio is 45.06. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RGI.L's ROE of +0.14%. Regarding short-term risk, 0K10.L is less volatile compared to 0RGI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IV3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IV3.L has a market cap of 980.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IV3.L trades at £1.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IV3.L's P/E ratio is -4.29. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IV3.L's ROE of -0.48%. Regarding short-term risk, 0K10.L is less volatile compared to 0IV3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0EE0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0EE0.L has a market cap of 896M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0EE0.L trades at £15.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0EE0.L's P/E ratio is 2.27. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0EE0.L's ROE of -4.84%. Regarding short-term risk, 0K10.L is less volatile compared to 0EE0.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JBU.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JBU.L has a market cap of 857.5M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JBU.L trades at £8.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JBU.L's P/E ratio is -1.63. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JBU.L's ROE of -0.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0JBU.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0O1O.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0O1O.L has a market cap of 843.7M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0O1O.L trades at £71.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0O1O.L's P/E ratio is 13.45. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0O1O.L's ROE of +0.10%. Regarding short-term risk, 0K10.L is less volatile compared to 0O1O.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JDK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JDK.L has a market cap of 794.5M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JDK.L trades at £2.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JDK.L's P/E ratio is -0.99. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JDK.L's ROE of -0.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0JDK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HFR.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HFR.L has a market cap of 669.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HFR.L trades at £8.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HFR.L's P/E ratio is -13.95. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HFR.L's ROE of -0.31%. Regarding short-term risk, 0K10.L is less volatile compared to 0HFR.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K16.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0K16.L has a market cap of 628M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0K16.L trades at £14.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0K16.L's P/E ratio is -11.22. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K16.L's ROE of -9.32%. Regarding short-term risk, 0K10.L is less volatile compared to 0K16.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QNA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QNA.L has a market cap of 624.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QNA.L trades at £50.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QNA.L's P/E ratio is -87.01. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QNA.L's ROE of +1.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0QNA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0W4N.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0W4N.L has a market cap of 486M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0W4N.L trades at £27.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0W4N.L's P/E ratio is -22.59. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0W4N.L's ROE of -0.24%. Regarding short-term risk, 0K10.L is less volatile compared to 0W4N.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0K3W.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0K3W.L has a market cap of 477.3M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0K3W.L trades at £5.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0K3W.L's P/E ratio is -47.51. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0K3W.L's ROE of -0.15%. Regarding short-term risk, 0K10.L is less volatile compared to 0K3W.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0OB3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0OB3.L has a market cap of 434.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0OB3.L trades at £2.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0OB3.L's P/E ratio is -3.74. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0OB3.L's ROE of -0.43%. Regarding short-term risk, 0K10.L is less volatile compared to 0OB3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RNK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RNK.L has a market cap of 411.8M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RNK.L trades at £2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RNK.L's P/E ratio is -2.34. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RNK.L's ROE of +1.98%. Regarding short-term risk, 0K10.L is less volatile compared to 0RNK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0DTF.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0DTF.L has a market cap of 403.7M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0DTF.L trades at £23.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0DTF.L's P/E ratio is 14.26. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0DTF.L's ROE of +0.03%. Regarding short-term risk, 0K10.L is more volatile compared to 0DTF.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RA9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RA9.L has a market cap of 369.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RA9.L trades at £5.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RA9.L's P/E ratio is -2.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RA9.L's ROE of -2.11%. Regarding short-term risk, 0K10.L is less volatile compared to 0RA9.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IGA.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IGA.L has a market cap of 343.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IGA.L trades at £6.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IGA.L's P/E ratio is 2.13. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IGA.L's ROE of -0.27%. Regarding short-term risk, 0K10.L is less volatile compared to 0IGA.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0LOV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0LOV.L has a market cap of 321.5M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0LOV.L trades at £5.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0LOV.L's P/E ratio is -14.23. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0LOV.L's ROE of +58.06%. Regarding short-term risk, 0K10.L is less volatile compared to 0LOV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0H7R.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0H7R.L has a market cap of 314.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0H7R.L trades at £6.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0H7R.L's P/E ratio is -7.61. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0H7R.L's ROE of -1.65%. Regarding short-term risk, 0K10.L is less volatile compared to 0H7R.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0J4V.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0J4V.L has a market cap of 299.1M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0J4V.L trades at £1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0J4V.L's P/E ratio is -0.86. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0J4V.L's ROE of +0.37%. Regarding short-term risk, 0K10.L is less volatile compared to 0J4V.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IIM.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IIM.L has a market cap of 236.8M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IIM.L trades at £1.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IIM.L's P/E ratio is -0.19. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IIM.L's ROE of +0.40%. Regarding short-term risk, 0K10.L is less volatile compared to 0IIM.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0GP7.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0GP7.L has a market cap of 234.8M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0GP7.L trades at £2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0GP7.L's P/E ratio is -1.27. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0GP7.L's ROE of -0.38%. Regarding short-term risk, 0K10.L is more volatile compared to 0GP7.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RDB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RDB.L has a market cap of 212.8M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RDB.L trades at £2.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RDB.L's P/E ratio is -31.19. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RDB.L's ROE of -0.03%. Regarding short-term risk, 0K10.L is less volatile compared to 0RDB.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QAV.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QAV.L has a market cap of 206.3M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QAV.L trades at £4.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QAV.L's P/E ratio is -3.34. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QAV.L's ROE of +2.83%. Regarding short-term risk, 0K10.L is less volatile compared to 0QAV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0NZY.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0NZY.L has a market cap of 201.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0NZY.L trades at £39.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0NZY.L's P/E ratio is 30.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0NZY.L's ROE of +0.14%. Regarding short-term risk, 0K10.L is more volatile compared to 0NZY.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IFK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IFK.L has a market cap of 164.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IFK.L trades at £1.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IFK.L's P/E ratio is -0.72. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IFK.L's ROE of -1.66%. Regarding short-term risk, 0K10.L is less volatile compared to 0IFK.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0H8T.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0H8T.L has a market cap of 159M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0H8T.L trades at £1.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0H8T.L's P/E ratio is -1.12. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0H8T.L's ROE of -0.94%. Regarding short-term risk, 0K10.L is less volatile compared to 0H8T.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QOI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QOI.L has a market cap of 146.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QOI.L trades at £7.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QOI.L's P/E ratio is -8.66. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QOI.L's ROE of +1.28%. Regarding short-term risk, 0K10.L is more volatile compared to 0QOI.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0N4A.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0N4A.L has a market cap of 142M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0N4A.L trades at £0.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0N4A.L's P/E ratio is -1.02. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0N4A.L's ROE of -0.23%. Regarding short-term risk, 0K10.L is more volatile compared to 0N4A.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0OCQ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0OCQ.L has a market cap of 127.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0OCQ.L trades at £0.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0OCQ.L's P/E ratio is -4.50. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0OCQ.L's ROE of -4.66%. Regarding short-term risk, 0K10.L is less volatile compared to 0OCQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0UNL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0UNL.L has a market cap of 125.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0UNL.L trades at £0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0UNL.L's P/E ratio is -0.31. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0UNL.L's ROE of -2.62%. Regarding short-term risk, 0K10.L is less volatile compared to 0UNL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R1D.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0R1D.L has a market cap of 122M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0R1D.L trades at £0.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0R1D.L's P/E ratio is -0.41. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R1D.L's ROE of -3.51%. Regarding short-term risk, 0K10.L is less volatile compared to 0R1D.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QN1.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QN1.L has a market cap of 121M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QN1.L trades at £12.46.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QN1.L's P/E ratio is -7.67. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QN1.L's ROE of -1.11%. Regarding short-term risk, 0K10.L is less volatile compared to 0QN1.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QXX.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QXX.L has a market cap of 112.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QXX.L trades at £3.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QXX.L's P/E ratio is 0.92. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QXX.L's ROE of -0.36%. Regarding short-term risk, 0K10.L is more volatile compared to 0QXX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0SZI.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0SZI.L has a market cap of 108.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0SZI.L trades at £8.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0SZI.L's P/E ratio is -28.34. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0SZI.L's ROE of -0.37%. Regarding short-term risk, 0K10.L is less volatile compared to 0SZI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0O8G.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0O8G.L has a market cap of 95.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0O8G.L trades at £3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0O8G.L's P/E ratio is -14.05. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0O8G.L's ROE of -6.17%. Regarding short-term risk, 0K10.L is more volatile compared to 0O8G.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KCC.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0KCC.L has a market cap of 75.3M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0KCC.L trades at £2.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0KCC.L's P/E ratio is -3.41. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KCC.L's ROE of -7.67%. Regarding short-term risk, 0K10.L is more volatile compared to 0KCC.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0Q77.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0Q77.L has a market cap of 70.1M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0Q77.L trades at £1.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0Q77.L's P/E ratio is -3.88. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0Q77.L's ROE of +0.26%. Regarding short-term risk, 0K10.L is more volatile compared to 0Q77.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HX7.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HX7.L has a market cap of 64.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HX7.L trades at £0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HX7.L's P/E ratio is -0.72. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HX7.L's ROE of -0.53%. Regarding short-term risk, 0K10.L is less volatile compared to 0HX7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HIY.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HIY.L has a market cap of 60.8M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HIY.L trades at £8.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HIY.L's P/E ratio is -2.45. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HIY.L's ROE of +0.18%. Regarding short-term risk, 0K10.L is less volatile compared to 0HIY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0RU5.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0RU5.L has a market cap of 53.5M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0RU5.L trades at £1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0RU5.L's P/E ratio is -0.39. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0RU5.L's ROE of -1.02%. Regarding short-term risk, 0K10.L is less volatile compared to 0RU5.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0DOL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0DOL.L has a market cap of 52.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0DOL.L trades at £1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0DOL.L's P/E ratio is 4.37. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0DOL.L's ROE of +0.03%. Regarding short-term risk, 0K10.L is more volatile compared to 0DOL.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0M40.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0M40.L has a market cap of 49M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0M40.L trades at £1.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0M40.L's P/E ratio is -1.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0M40.L's ROE of -0.59%. Regarding short-term risk, Volatility data is not available for a full comparison. 0K10.L has daily volatility of 0.16 and 0M40.L has daily volatility of N/A.
0K10.L vs 0HOH.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HOH.L has a market cap of 48.7M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HOH.L trades at £8.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HOH.L's P/E ratio is -0.77. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HOH.L's ROE of +18.95%. Regarding short-term risk, 0K10.L is less volatile compared to 0HOH.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JGL.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JGL.L has a market cap of 47.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JGL.L trades at £1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JGL.L's P/E ratio is -0.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JGL.L's ROE of -0.59%. Regarding short-term risk, 0K10.L is less volatile compared to 0JGL.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0R3M.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0R3M.L has a market cap of 42.7M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0R3M.L trades at £1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0R3M.L's P/E ratio is -2.59. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0R3M.L's ROE of -1.88%. Regarding short-term risk, 0K10.L is less volatile compared to 0R3M.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JQ2.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JQ2.L has a market cap of 28.9M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JQ2.L trades at £4.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JQ2.L's P/E ratio is N/A. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JQ2.L's ROE of -3.69%. Regarding short-term risk, 0K10.L is less volatile compared to 0JQ2.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QKQ.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QKQ.L has a market cap of 28.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QKQ.L trades at £2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QKQ.L's P/E ratio is -224.00. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QKQ.L's ROE of -0.40%. Regarding short-term risk, 0K10.L is less volatile compared to 0QKQ.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0IL8.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0IL8.L has a market cap of 27.1M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0IL8.L trades at £0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0IL8.L's P/E ratio is -0.09. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0IL8.L's ROE of +0.05%. Regarding short-term risk, 0K10.L is less volatile compared to 0IL8.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0QFK.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0QFK.L has a market cap of 25M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0QFK.L trades at £0.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0QFK.L's P/E ratio is -0.55. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0QFK.L's ROE of +0.91%. Regarding short-term risk, 0K10.L is more volatile compared to 0QFK.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0T6G.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0T6G.L has a market cap of 20.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0T6G.L trades at £1.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0T6G.L's P/E ratio is -35.27. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0T6G.L's ROE of -1.80%. Regarding short-term risk, 0K10.L is less volatile compared to 0T6G.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0JW9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0JW9.L has a market cap of 15.5M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0JW9.L trades at £2.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0JW9.L's P/E ratio is -4.32. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0JW9.L's ROE of -1.27%. Regarding short-term risk, 0K10.L is more volatile compared to 0JW9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0YC0.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0YC0.L has a market cap of 14.6M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0YC0.L trades at £0.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0YC0.L's P/E ratio is -0.79. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0YC0.L's ROE of -2.74%. Regarding short-term risk, 0K10.L is more volatile compared to 0YC0.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0KF3.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0KF3.L has a market cap of 5.1M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0KF3.L trades at £0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0KF3.L's P/E ratio is -0.70. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0KF3.L's ROE of +4.54%. Regarding short-term risk, 0K10.L is less volatile compared to 0KF3.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs CBX.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, CBX.L has a market cap of 2.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while CBX.L trades at £0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas CBX.L's P/E ratio is -0.37. In terms of profitability, 0K10.L's ROE is -5.82%, compared to CBX.L's ROE of -0.93%. Regarding short-term risk, 0K10.L is less volatile compared to CBX.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs KNB.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, KNB.L has a market cap of 1.4M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while KNB.L trades at £0.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas KNB.L's P/E ratio is -0.23. In terms of profitability, 0K10.L's ROE is -5.82%, compared to KNB.L's ROE of -1.22%. Regarding short-term risk, 0K10.L is more volatile compared to KNB.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0L85.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0L85.L has a market cap of 1.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0L85.L trades at £0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0L85.L's P/E ratio is -0.00. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0L85.L's ROE of -19.05%. Regarding short-term risk, 0K10.L is more volatile compared to 0L85.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0HL9.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0HL9.L has a market cap of 1.2M. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0HL9.L trades at £0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0HL9.L's P/E ratio is -0.12. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0HL9.L's ROE of -1.94%. Regarding short-term risk, 0K10.L is more volatile compared to 0HL9.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.
0K10.L vs 0G99.L Comparison
0K10.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0K10.L stands at 24.3B. In comparison, 0G99.L has a market cap of 297.9K. Regarding current trading prices, 0K10.L is priced at £1,171.16, while 0G99.L trades at £0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0K10.L currently has a P/E ratio of 34.40, whereas 0G99.L's P/E ratio is -0.36. In terms of profitability, 0K10.L's ROE is -5.82%, compared to 0G99.L's ROE of -0.01%. Regarding short-term risk, 0K10.L is more volatile compared to 0G99.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0K10.L.